Quantification Of Endogenous Anabolic Androgenic Steroids Using Gas Chromatography Tandem Mass Spectrometry: An Application Of Steroid Profile From Eurycoma Longifolia Administration by Abushareeda, Wadha Masoud
QUANTIFICATION OF ENDOGENOUS ANABOLIC 
ANDROGENIC STEROIDS USING GAS 
CHROMATOGRAPHY TANDEM MASS 
SPECTROMETRY; AN APPLICATION OF STEROID 
PROFILE FROM EURYCOMA LONGIFOLIA 
ADMINISTRATION 
 
 
 
 
 
 
By 
 
Wadha Masoud Abushareeda 
 
 
Thesis submitted in fulfillment of the requirements 
For the degree of 
Master of Science 
2011 
 
  
  ii 
 
ACKNOWLEDGMENTS 
 
Foremost, Praise is due to the Almighty ALLAH, the compassionate and most 
merciful for allowing me to finalise the current Master project safely and hope 
successfully.  
  I would like to express my sincere gratitude to my supervisor Prof. Aishah 
A.Latiff for her unfailing support to my master in its theoretical and practical stages; her 
patience, motivation, enthusiasm, and for her enriching and valuable comments and 
suggestions. I extended my thanks and appreciation to Dr. Alsayrafi the General Manager 
of Anti-doping Lab Qatar for his support. 
  I am also grateful to Hj. Normaliza for her co-supervision, guidance, and 
technical assistance throughout my study. Special thanks are due to Dr. Micheal Khalil 
for his consultation and valuable lectures. Besides, I would like to thank my friend 
Khadija and fellow friends in Anti-doping lab Qatar for their help and encouragement. I 
am also indebted to the Polis Tentera Diraja Malaysia for providing 27 volunteers to be 
involved in this study.  
Moreover, my heartfelt thanks go to Qatar Olympic Committee and to Anti-
Doping Lab Qatar for granting me a scholarship and for providing the necessary financial 
support to finalise this work and put it in its final form. 
Last but not least, I am very grateful to my brother Salem for his wonderful 
companionship along the whole period of my study. Sincere thanks are also to my 
parents, to my dear daughter Noora, my aunt Damtha and all my family members for 
their great patience and support during this project.   
  iii 
 
TABLE OF CONTENTS 
      Title                  Page 
ACKNOWLEDGMENTS ........................................................................................ ii 
LIST OF TABLES ................................................................................................ viii 
LIST OF FIGURES ................................................................................................ ix 
LIST OF ABBREVIATIONS ................................................................................. xi 
LIST OF APPENDICES ....................................................................................... xiii 
ABSTRACT ......................................................................................................... xvi 
CHAPTER 1 ............................................................................................................ 1 
INTRODUCTION ................................................................................................... 1 
1.1 Objectives .................................................................................................. 4 
CHAPTER 2 ............................................................................................................ 5 
LITERATURE REVIEW ......................................................................................... 5 
2.1 Endogenous Anabolic Androgenic Steroids and Abuse in sport .......................... 5 
2.1.1 Chemical structure of steroids and Steroidogenesis ...................................... 6 
2.1.2 Metabolism of Steroids ................................................................................ 7 
2.2 Detection of Anabolic Androgenic Steroids in Human Urine in Doping Control11 
2.2.1 History of Testing .......................................................................................11 
2.2.2 Strategy of Testing......................................................................................11 
2.2.3Analytical Techniques for Detecting Steroids ..................................................12 
2.2.3.1 Measurement of Steroids by Chromatography and Mass Spectrometry ....14 
  iv 
 
2.2.3.1.1 Mass Spectrometry ............................................................................15 
2.2.3.1.2 Gas Chromatography/Tandem Mass Spectrometry ............................17 
2.2.3.1.2.1 Principle of Gas Chromatography/Tandem Mass Spectrometry 
(GC/MS/MS) ...................................................................................................18 
2.2.3.1.2.2 Advantages and Application of GC/MS/MS: ..................................20 
2.3 Eurycoma Longifolia Jack (Tongkat Ali) ...........................................................21 
2.3.1 Reviews on the biological effects of Eurycoma longifolia ...........................23 
CHAPTER 3 ...........................................................................................................26 
MATERIALS AND METHODS ............................................................................26 
3.1 Materials ...........................................................................................................26 
3.1.1 Chemicals, Solvents and Reagents ..............................................................26 
3.1.2 Standards ....................................................................................................26 
3.1.3 Preparation of Reagents ..............................................................................27 
3.1.3.1 Solid buffer (potassium carbonate: sodium bicarbonate 1:2 w/w) .........27 
3.1.3.2 Preparation of Glucuronidase enzyme from E.coli (5000 IU) ................27 
3.1.3.3 Preparation of Potassium dihydrogen phosphate, 0.1 M ........................27 
3.1.3.4 Preparation of dipotassium hydrogen phosphate, 0.1 M ........................27 
3.1.3.5 Preparation of phosphate buffer, 0.1 M, pH 6.8 ....................................28 
3.1.4 Preparation of Internal standards .................................................................28 
3.1.4.1 Preparation of internal standards stocks (200 µg/mL) ...........................28 
3.1.4.2 Preparation of internal standards mixture (10 µg/mL) ...........................29 
  v 
 
3.1.4.3 Preparation of D4-androsterone glucuronide and D5-etiocholanolone 
mixture (50 µg/mL) .........................................................................................29 
3.1.5 Preparation of reference Standards ..............................................................29 
3.1.5.1 Preparation of working solution 5 µg/mL of testosterone and 
epitestosterone .................................................................................................30 
3.1.5.2 Preparation of working solution 250 ng/mL of testosterone and 
epitestosterone .................................................................................................30 
3.1.5.3 Preparation of working solution 100 µg/mL of Androsterone and 
Etiocholanolone ...............................................................................................30 
3.1.5.4 Preparation of working solution 50 µg/mL of Androsterone and 
Etiocholanolone ...............................................................................................30 
3.1.5.5 Preparation of working solution 10 µg/mL of 5α-androstandiol, 5β-
androstandiol, dihydrotestosterone, dehydroepiandrosterone, 5- androstenediol 
and 4-androstenedione .....................................................................................31 
3.1.5.6 Preparation of working solution 2 µg/mL of 5α-androstandiol, 5β-
androstandiol, dihydrotestosterone, dehydroepiandrosterone, 5- androstenediol 
and 4-androstenedione .....................................................................................31 
3.1.6 Preparation of Calibration Standards ...........................................................31 
3.1.6.1 Calibration standards of  Testosterone and Epitestosterone ...................32 
3.1.6 .2 Calibration standards of Androsterone and Etiocholanolone ................32 
3.1.6.3 Calibration standards of 5α-androstandiol, 5β-androstandiol, 
dihydrotestosterone, dehydroepiandrosterone, 5- androstenediol and 4-
androstenedione ...............................................................................................33 
  vi 
 
3.1.7 Preparation of Quality Control ....................................................................33 
3.1.7.1 Preparation of mid-point quality control samples ..................................34 
3.1.7.2 Preparation of low level quality control samples ...................................34 
3.2 Methods ............................................................................................................35 
3.2.1 Subjects and Administration Protocol .........................................................35 
3.2.2 Analytical methods .....................................................................................36 
3.2.2.1 Extraction method ................................................................................37 
3.2.2.2 Instrumentation and conditions .............................................................38 
3.2.2.2.1 Mass spectrometry optimisation ........................................................39 
3.3 Method Validation ............................................................................................40 
3.4 Statistical methodology .....................................................................................41 
RESULTS AND DISCUSSION ..............................................................................43 
4.1 Method Optimization and Validation.................................................................43 
4.1.1 GC Conditions ............................................................................................43 
4.1.2 Mass Spectrometry Optimisation ................................................................45 
4.1.3 Method Validation ......................................................................................50 
4.1.3.1 Specificity ............................................................................................50 
4.1.3.2 Linearity...............................................................................................51 
4.1.3.3 Limit of Detection and Limit of Quantification .....................................51 
4.1.3.4 Precision and Accuracy ........................................................................52 
4.1.3.5 Extraction Recovery .............................................................................52 
4.1.3.6 Robustness of the method .....................................................................53 
  vii 
 
4.2 Application and the Administration Study Results .............................................54 
4.2.1 The Effect of Eurycoma longifolia on the Level of Testosterone, 
Epitestosterone and T/E ratio ...............................................................................55 
4.2.1.1 Testosterone Level ...............................................................................55 
4.2.1.2 Epitestosterone Level ...........................................................................58 
4.2.1.3 Testosterone to Epitestosterone ratio (T/E ratio) ...................................60 
4.2.2 The effect of Eurycom longifolia on the precursors and metabolites of 
testosterone .........................................................................................................64 
4.2.2.1 Testosterone precursors ........................................................................64 
4.2.2.2 Testosterone metabolites ......................................................................70 
CHAPTER 5 ...........................................................................................................83 
SUMMARY AND CONCLUSIONS ...................................................................83 
BIBLIOGRAPHY ...................................................................................................86 
APPENDICES ........................................................................................................94 
 
  
  viii 
 
LIST OF TABLES 
Table Title Page 
Table 3.1 Preparation of Testosterone and Epitestosterone calibration standards. 32 
Table 3.2 Preparation of Androsterone and Etiocholanolone calibration standards. 32 
Table 3.3 Preparation of 5α-androstandiol, 5β-androsatndiol, dihydrotestosterone, 
dehydroepiandrosterone, 5- androstendiol and 4-androstenedione 
calibration standards. 
33 
Table 4.1 GC-MS/MS data of the compound studied 49 
Table 4.2 Limit of detection, quantification and calibration results 52 
Table 4.3 Intra-day and inter-day validation results of the overall method. 53 
Table 4.4 Descriptive statistics showing Testosterone level among different groups 56 
Table 4.5 Descriptive statistics showing Epitestosterone level among different 
groups 
59 
Table 4.6 Descriptive statistics showing T/E ratio among the different groups. 62 
Table 4.7 Descriptive statistics showing DHEA level among different groups 65 
Table 4.8 Descriptive statistics showing 4-Androstenedione level among different 
groups 
68 
Table 4.9 Descriptive statistics showing 5-androstenediol  level among different 
groups 
68 
Table 4.10 Descriptive statistics showing androsterone level among different groups 73 
Table 4.11 Descriptive statistics showing Etiocholanolone level among different 
groups 
73 
Table 4.12 Descriptive statistics showing DHT level among different groups 76 
Table 4.13 Descriptive statistics showing 5-α-androstandiol level among different 
groups 
77 
Table 4.14 Descriptive statistics showing 5-β-androstandiol level among different 
groups 
77 
  
  ix 
 
LIST OF FIGURES 
 
Figure Title  Page 
Figure 2.1 General Structure and carbon numbering of steroids. 6 
Figure 2.2 Steroidogenesis (Adaptedfrom: Korne et al, 2010) 9 
Figure 2.3 Metabolic scheme of testosterone and its prohormones: 1, 
dehydroepiandrosterone; 2, androst-5-ene-3β,17β-diol; 3, androst-5-ene-
3,17-dione; 4,androst-4-ene-3,17-dione; 5, testosterone; 6, androst-4-ene-
3β,17 β -diol; 7, 5α- and 5β -androstandione; 8, 5αand 5β -
dihydrotestosterone; 9, 5β -androstan-3β,17β -diol; 10, androsterone 
(5α)and etiocholanolone (5 β); 11, 5α - and 5β -androstan-3α,17β -diol; 12, 
5α -androstan-3βα,17β –diol (adapted from: Eenoo & Delbeke, 2006).  
10 
Figure 2.4 Schematic diagram of Mass Spectrometer. 16 
Figure 2.5 Shematic diagram of  MS/MS adapted from: 
http://www.medandlife.ro/medandlife418.html. 
19 
Figure 2.6 Eurycoma longifolia root (adapted from http://tong-kat-ali.com/buying-
tongkat-ali-extract.html). 
22 
Figure 3.1 Gas chromatography tandem mass spectrometer. 38 
Figure 4.1  The effect of temperature programme on the peak separation for 5-α-
androstandiol and 5-β-androstandiol is as follows:A) The initial 
temperature was 180 ºC hold for 1 min, ramped at 10 ºC/min to 220 ºC, 
ramped at 2 ºC/min to 230 ºC, ramped at 60 ºC/min to 320 ºC, hold for 2 
min. B) Initial temperature was 180 ºC hold for 1 min, ramped at 10 ºC/min 
to 230 ºC, ramped at 2 ºC/min to 240 ºC, ramped at 60 ºC/min to 320 ºC, 
hold for 2 min. C) Initial temperature was 180 ºC hold for 1 min, ramped at 
5 ºC/min to 230 ºC, ramped at 60 ºC/min to 320 ºC, hold for 2 min.  
 
44 
Figure 4.2 The resolution achieved between androsterone and etiocholanolone peaks 
(<10% vally) by the optimised temperature ramping. 
45 
Figure 4.3 Chemical Structure of Derivatised Testosterone, Mol.wt: 432. 47 
Figure 4.4 Full scan spectrum of testosterone with the actual parent and the most 
abundant ion highlighted. 
47 
  x 
 
Figure 4.5 Testosterone product ion scan (30 eV collision energy) of mass 432. 47 
Figure 4.6 Optimisation of CE for the testosterone quantification ion (209): A) 
at CE 5 eV, B) at CE 8 eV, C) at CE 10 eV, D) at CE 15 eV, E) at 
CE 18 eV, F) at CE 20 eV, G) at CE 23 eV, H) at CE 25 eV, I) at CE 
28 eV, J) at CE 30 eV. This figure illustrates that CE at 18 V can 
give the best abundance, and therefore highest sensitivity for the ion 
48 
 
Figure 4.7 The mean concentration of the testosterone among (a) athletes group (b) 
non-athletes group. 
58 
Figure 4.8 The mean concentration of the epitestosterone among (a) athletes group 
and (b) non-athletes group. 
60 
Figure 4.9 The mean concentration of the DHEA among (a) athletes group and (b) 
non-athletes group. 
67 
Figure 4.10 The mean concentration of the 4-androstenedione among (a) athletes group 
and (b) non-athletes group. 
69 
Figure 4.11 The mean concentration of the 5-androstenediol among (a) athletes group 
and (b) non-athletes groups. 
70 
Figure 4.12 The mean concentration of the androsterone among (a) athletes groups and 
(b) non-athletes group. 
74 
Figure 4.13 The mean concentration of the etiocholanolone among (a) athletes groups 
and (b) non-athletes groups. 
75 
Figure 4.14 The mean concentration of the DHT among (a) athletes group and (b) non-
athletes group. 
78 
Figure 4.15 The mean concentration of the 5-α-androstandiol among (a) athletes group 
and (b) non-athletes group. 
79 
 
Figure 4.16 The mean concentration of the 5-β-androstandiol among (a) athletes group 
and (b) non-athletes group. 
80 
 
  
  xi 
 
LIST OF ABBREVIATIONS 
CE  collosion energy 
DHEA  dehydroepiandrosterone 
E   Epitestosterone  
E.coli  Escherichia Coli 
EAAS   Endogenous androgenic anabolic steroids  
GC/MS Gas chromatography mass spectrometry 
GC-MS/MS  Gas chromatography tandem mass spectrometry  
H
+
  Hydrogen ion 
HPLC   High performance liquid chromatography  spectrometry 
LC-MS-MS Liquid chromatography mass  spectrometry 
IOC   International Olympic Committee  
ISL  International Standard for Laboratories 
K
+
  Potassium ion 
LLE   Liquid-liquid extraction  
LOD   limit of detection  
LOQ   Limit of quantification  
m/z  mass-to-charge ratio  
MRM   Multiple Reaction Monitoring  
MSTFA    N-methyl-N-(trimethylsilyl) trifluoroacetamide  
Na
+
   Sodium ion 
NATA  National Association of testing Authorities, Australia 
ᵒC  Celsius temperatures 
r
2  
correlation coefficients  
RIA   radioimmunoassay  
SIM   selected ion monitoring mode 
SPE   solid phase extraction  
  xii 
 
T   testosterone  
T/E ratio Testosterone to Epitestoerone 
TMS  trimethylsilyl 
UHQ   ultra-high quality  
WADA           World Anti-doping Agency  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  xiii 
 
LIST OF APPENDICES 
Appendix Title Page 
A Full Scan Spectrum  and Product Ion Scan of Epitestosterone 94 
B Full Scan Spectrum and Product Ion Scan of Androsterone 95 
C Full Scan Spectrum  and Product Ion Scan of  Etiocholanolone 96 
D Full Scan Spectrum  and Product Ion Scan of 5-α-androstandiol 97 
E Full Scan Spectrum  and Product Ion Scan of 5-β-androstandiol 98 
F Full Scan Spectrum  and Product Ion Scan of 
Dehydroepiandrosterone 
99 
G Full Scan Spectrum  and Product Ion Scan of  Dihydrotestosterone 100 
H Full Scan Spectrum  and Product Ion Scan of 4-androstenedione 101 
I Calibration Curve of Testosterone 102 
J Calibration Curve of Epitestosterone    103 
K Calibration Curve of Androsterone 104 
L Calibration Curve of 5-α-androstandiol 105 
M Calibration Curve of 5-β-androstendiol 106 
N Calibration Curve of Dehydroepiandrosterone 107 
O Calibration Curve of Dihydrotestosterone 108 
P Calibration Curve of 5-androstenediol 109 
Q Calibration Curve of 4-androstenedione 110 
S Calibration Curve of Etiocholanolone 111 
R Volunteer's Survey Form 112 
T Research information and Consent form 113 
   
  xiv 
 
 
Kuantifikasi Steroid Endogenous Anabolik Androgenik dengan menggunakan 
Kromatografi Gas-Spektrometri Jisim: Aplikasi profil steroid dari administrasi 
Eurycoma longifolia 
  
ABSTRAK 
Kaedah yang menggunakan kromatografi gas-spektrometri tandem jisim 
(GC-MS/MS) telah dibangun untuk menentukan paras steroid endogenous 
androgenik anabolik (EAAS) termasuk testosteron, dehidroepiandrosteron, 4-
androstenedione, 5-androstenediol, dihidrotestosteron serta beberapa metabolit 
berkaitan seperti androsteron, etiokolanolon, 5-α-androstandiol dan 5-β-
androstandiol dalam sampel urin.Sampel urin telah diekstrak melalui kaedah 
pengekstrakan Fasa Pepejal (SPE) dan dianalisis melalui teknik GC-MS/MS. 
Pemonitoran Tindakbalas Multipel (Multiple Reaction Monitoring, MRM) telah 
diguna untuk analisis tersebut dengan mengguna kan dua transisi MRM sebagai ion 
kualifikasi dan satu transisi MRM sebagai ion kuantifikasi bagi setiap steroid. 
Kelinearan, peratus perolehan semula pengekstrakan, LOD, ketepatan dan kejituan 
analisis intra-hari dan inter-hari dan juga kebolehtahanan kaedah telah dijalankan 
kajian pengesahan. Korelasi ko-efisikasi (r
2
) yang diperolehi adalah melebihi 0.993 
untuk semua sebatian. Peratus perolehan semula yang dicapai dengan menggunakan 
kaedah ini adalah melebihi 70% untuk kesemua analit. Had pengesanan yang 
diperolehi menggunakan kaedah yang dibentangkan di dalam kajian ini adalah dari 
julat 0.1 hingga 0.2 ng/mL. Had penentuan pula adalah dari 0.5 hingga 1 ng/mL. 
Keputusan kajian menunjukkan kejituan yang baik dimana CV < 8% dan  ketepatan 
≥ 80% untuk kesemua sebatian dan untuk semua peringkat assay.  Keputusan 
pengesahan menunjukkan bahawa kaedah analisis yang digunakan dalam kajian ini 
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untuk kuantifikasi steroid anabolik dalam urin dapat memenuhi kriteria bagi validasi 
kaedah kuantitatif mengikut WADA ISL dan Nota Teknikal NATA. 
EAASialah suatu kumpulan sebatian semulajadi yang menyerupai testosteron 
secara kimia dan mempunyai tindak balas androgenik anabolik yang serupa. 
Administrasi bahan-bahan ini untuk peningkatan prestasi atlit dilarang dalam sukan. 
Penyalahgunaan steroid dianggap sebagai suatu langgaran yang amat serius dalam 
sukan. Eurycoma longifolia ialah suatu tumbuhan herba yang berasal dari negara 
Tenggara Asia yang diakui boleh meningkatkan paras testosteron. Justeru itu, ia 
diguna dalam kalangan atlit dan ahli bina badan untuk merangsang jisim otot, 
kekuatan atlit dan keseluruhanprestasi.  Dalam kajian ini, 27 sukarelawan telah 
dikenalpasti untuk mengambil Eurycoma longifolia untuk jangkamasa 15 hari dan 
sampel urindari setiap subjek telah dikumpul setiap lima hari.  Kuantifikasi EAAS 
selepas administrasi Eurycoma longifolia telah dianalisis dengan menggunakan 
kaedah GC/MS/MS yang telah dibangunkan. Keputusan dari kajian ini menunjukkan 
suatu peningkatan signifikan dalam paras testosteron serta prekursor dan metabolit 
steroid untuk jangkamasa 5 hari. Sungguhpun tiada terdapat perbezaan yang 
signifikan dalam paras EAAS antara kumpulan atlit dengan bukan-atlit dan juga 
antara kumpulan yang mengambil Eurycoma longifolia dngan kumpulan plasebo, 
jelas terdapat perbezaan yang signifikan dalam paras steroid mengikut fungsi masa.  
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Quantification of Endogenous Anabolic Androgenic Steroids using Gas 
Chromatography Tandem Mass Spectrometry; an application of steroid profile 
from  Eurycoma longifolia administration 
ABSTRACT 
 
A method was developed using gas chromatography tandem mass 
spectrometry (GC/MS/MS) to quantify the levels of endogenous androgenic anabolic 
steroids (EAAS) including testosterone, dehydroepiandrosterone, 4-andro -
stenedione, 5-androstenediol, dihydrotestosterone and other related metabolites like 
androsterone, etiocholanolone, 5-α-androstandiol and 5-β-androstandiol   in urine 
samples. The steroids were extracted using SPE method followed by LLE and 
analyzed by GC/MS/MS. Multiple Reaction Monitoring (MRM) was adopted for the 
analysis, using two MRM transitions as the qualifier ions and one MRM transition as 
the quantifier ion for each analyte. The linearity, extraction recovery, LOD, intra- 
and inter–day precision and accuracy as well as robustness of the method were 
validated. The correlation coefficients (r
2
) obtained was higher than or equal to 0.993 
for all the compounds. The recoveries achieved using the method were higher than 
70% for all analytes The limits of detection that was obtained using the method 
described in the present study ranged from 0.1 to 0.2 ng/mL. The limits of 
quantification ranged from to 0.5 to 1 ng/mL. The results showed good precision; 
where CV < 8% and accuracy ≥ 80% for all compounds in all assayed levels.  The 
validation results showed that the analytical method used in this study to quantify the 
investigated anabolic steroids in urine has complied with the criteria of the validation 
for quantitative methods according to WADA ISL and NATA Technical Note.  
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EAAS is a group of natural compounds that are chemically similar to 
testosterone and share the same androgenic anabolic action. Administration of these 
substances for enhancement of athletic performance is forbidden in sport.  Abuse of 
these steroids is one of the most serious violations in sport. Eurycoma longifolia is an 
herbal plant native to South East Asian countries which is claimed to boost the 
testosterone levels. Accordingly, it is used among the athletes and bodybuilders to 
enhance the muscle mass, strength, and the overall performance. In this study, 27 
volunteers were recruited to consume Eurycoma longifolia over a period of 15 days 
and the urine sample of each subject was collected every five days. Quantification of 
EAAS after administration of Eurycoma longifolia was carried out using GC-MS/MS 
method. Results of the administration study showed a significant increase during the 
first five days in the urinary levels of the testosterone and related steroid precursors 
and metabolites. Although there were no significant differences in the levels of 
EAAS between the athletes and non-athletes group as well as between treated and 
placebo group, there were clearly significant differences in the levels as a function of 
time. 
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CHAPTER 1 
INTRODUCTION 
Enhancing athletic performance by administrating foreign substances is 
forbidden in human sports. The global fight against doping in sports is supervised by 
the World Anti-Doping Agency (WADA). The latter maintains the World Anti-
Doping Code, which in return includes the WADA Prohibited List, which defines the 
substances and methods prohibited in sports. In practice, drug abuse is controlled via 
testing athletes. Urine or blood samples are collected from athletes, either prior to or 
during competition. Test samples are analysed in analytical laboratories accredited 
by WADA to check whether or not they have banned substances. 
Anabolic Androgenic Steroids (AAS) are a group of natural and synthetic 
compounds that are chemically similar to and mimic the actions of endogenous 
testosterone. In addition to their medical use, AAS has been misused for the past 50 
years by a wide variety of athletes in the hope of improving their training, endurance 
and performance. The use of AAS in sports has been banned since the mid-70s, and 
it is still the most misused class of drugs in sports today. Steroid abuse has also 
become more and more prevalent outside the field of sports. 
Detecting AAS is considered a challenge due to the presence of numerous 
different synthetic steroids, their extensive metabolism in the body and to their low 
concentration in urine. A capillary gas chromatograph coupled to a bench top 
quadrupole mass spectrometer (GC/MS) is considered the backbone when testing 
AAS during the last decade. Although the set-up fairly allows successful large scale 
screening, more efficient instrumental techniques, such as high resolution mass 
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spectrometry (HRMS), tandem mass spectrometry (MS/MS) and liquid 
chromatography mass spectrometry (LC/MS) are needed to enhance the selectivity 
and sensitivity of the measurements.  Most of the LC/MS-based methods that are 
used for the purpose of detecting anabolic steroids use tandem mass spectrometry 
instruments in a selected reaction monitoring (SRM) mode due to its specificity and 
selectivity. Additionally, the selection of a specific SRM transition can minimize the 
endogenous urinary interferences. Using this approach, free or conjugated steroids 
could be detected in different various matrices, such as human and horse urine, 
dietary supplements, plasma or hair. The main limitation of this approach (common 
to all LC/MS approaches) is the poor ionization efficiency of steroids in electrospray 
ionization; especially, in case of steroids that do not have a conjugated keto moiety 
(Pozo et al., 2011). In addition, LC typically does not provide as high a resolution as 
that of the GC and therefore it may pose some difficulty in separating analytes with 
very closely related structures (Stanczyk & Clarke, 2010). 
While the advent of LC/MS/MS in the past decades has resulted in dramatic 
improvements with respect to sensitivity, specificity and automated measurements of 
serum steroid hormone, there are still situations where the GC/MS or GC/MS/MS 
assay provides higher chromatographic resolution and even sensitivity. A particular 
strength of GC/MS and GC/MS/MS stems from their high applicability to measure 
large numbers of structurally similar analytes. The recent availability of GC/MS/MS 
systems extends the capability of drug doping laboratories by providing the ability to 
screen, confirm, and to quantify prohibited compounds in one run, or even in 
complex matrices (Latiff & Churley, 2009). 
Eurycoma longifolia Jack is a herbal plant that is native to South East Asian 
countries, mainly to Malaysia and Indonesia. It is popularly recognized as ‘Tongkat 
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Ali’, which means the ‘walking stick’; it is derived from the presence of long twisted 
roots (Bhat & Karim, 2010). It is claimed that the regular intake of root extracts is 
believed to enhance the testosterone levels. An increased interest has also been 
created among athletes and individuals, who are involved in body building with 
respect to using such an extract in enhancing muscle mass, strengthening the overall 
performance (Bhat & Karim, 2010).  
Due to these reasons, this study was proposed to monitor the level of 
testosterone and other endogenous steroid precursors and metabolites to ensure that 
the intake of Eurycoma longifolia is not categorized as doping. If Eurycoma 
longifolia has the ability to increase the testosterone level, the ratio of testosterone to 
epitestosterone (T/E ratio) should be closely monitored. Otherwise, the use may 
result in preventing athletes from practicing any sports event and in prohibiting 
Eurycoma longifolia as a supplement.  
In order to establish the effects of Eurycoma longifolia on steroids and steroid 
metabolism, a group of volunteers will be identified to consume Eurycoma longifolia 
over a period of 15 days. Then, the urine of each subject will be collected every five 
days following the process of administration. Gas chromatography with tandem mass 
spectrometry techniques will be used to quantify all endogenous steroids that are 
considered an important indicator to steroid abuse and as important parameters to 
Athletes' Biological Passport. 
The findings of this study will resolve the question of whether Eurycoma 
longifolia can be used among the athletes. If Eurycoma longifolia is shown to have a 
significant effect on the testosterone and other endogenous steroids levels, the 
National Sport Institute must prohibit athletes from taking Eurycoma longifolia as 
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supplements. Currently, Eurycoma longifolia has been widely used as a supplement 
to increase energy and to enhance the performance of athletes. 
1.1 Objectives 
 
There are two main objectives within the current study; that include 
the following:  
1- Developing, optimising and validating a method for quantifying AAS in urine 
using gas chromatography tandem mass spectrometry using a GC-triple 
quadrupole system. 
2- Quantifying testosterone and other endogenous anabolic androgenic steroids 
(EAAS) following oral administration of Eurycoma longifolia in volunteers’ 
urine. 
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CHAPTER 2 
LITERATURE REVIEW 
 
 This chapter is an introductory chapter that presents a general background on 
the endogenous anabolic androgenic steroids, the method of analysis and the 
technique used, and a revision reviews on Eurycoma longifolia Jack.  
2.1 Endogenous Anabolic Androgenic Steroids and Abuse in sport 
 
Abuse of endogenous anabolic androgenic steroids (EAAS) is one of the most 
serious violations in sport. Such a type of steroids is misused by athletes to increase 
muscle mass and to enhance the physical performance. The misuse of these steroids 
in sport has led to issue a ban by the International Olympic Committee (IOC) in 1974 
and by the World Anti-doping Agency (WADA) since 2003. The latter organization 
encouraged sport drug testing laboratories to develop the screening methods that help 
to detect the anabolic steroids in urine (Fragkaki, 2009). Doping Control 
Laboratories have been confronted with the challenge of finding criteria that allow 
endogenous steroids to be distinguished from their synthetic analogues in the urine of 
athletes. 
These EAAS are derived from the naturally occurring steroid testosterone 
(T), which is considered the most important androgenic steroid (Renterghem, 2008).  
In spite of the increasing popularity of synthetic steroids, naturally occurring steroids 
are still widely misused in sports. Intake of endogenous steroids affects altering one 
or more parameters of the urinary steroid profile which currently include testosterone 
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(T), epitestosterone(E) , androsterone, etiocholanolone, 5-α-androstandiol and 5-β 
androstandiol ( WADA, TD2009EAAS) 
2.1.1 Chemical structure of steroids and Steroidogenesis 
 
Steroid hormones are fat soluble hormones that are derived in specific tissues in the 
body. As far as the structure of steroids; they have a core frame of four carbon rings, 
three cyclohexanes, one cyclopentane and additional functional groups that are 
attached to the rings (Figure 2.1). 
 
Figure 2.1 General Structure and carbon numbering of steroids 
 
Cholesterol, which contains 27 carbon atoms (C27), is a commonly-known 
steroid that acts as a precursor to all five major groups of steroid hormones: 
progestagens (C21), mineralocorticoids (C21), glucocorticoids (C21), androgens 
(C19), and estrogens (C18). As for steroid hormones, they contain 21 or fewer 
carbons. 
       Pregnenolone, a precursor of all other steroid hormones, is the first 
steroidhormone that is synthesized from cholesterol by the cleavage of a bond 
between C-20 and C-22. It is further one of the progestagens that maintains 
menstrual cycles and pregnancy. Pregnenolone is converted into progesterone, a 
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major precursor of four other steroid hormone groups. Cortisol, a major component 
of glucocorticoids, is produced from progesterone, which breaks down fat and 
protein to form glycogen to maintain the normal levels of glucose in blood. 
Aldosterone, the major mineralocorticoid, is synthesized from progesterone through 
corticosterone. Mineralocorticoids are responsible for increasing the reabsorption of 
Na
+
, and the excretion of K
+
 and H
+
. The latter helps increase the amount of water to 
adjust blood volume and pressure. Progesterone can be converted into 
androstenedione when a few intermediates go through the cleavage of the two carbon 
chains at the C-17 position; a process that results in C19 androgens. Testosterone is 
synthesized from androstenedione by reduction of the keto group on C-17. 
Androstenedione is also a precursor of estrogens; the predominant one of the three 
estrogens is estradiol, which is responsible for the development of female secondary 
sex characteristics (Makin et al., 1995). Estrogens are synthesized by the loss of 
methyl group on C-19; a matter that results in having C18 structure (Figure 2.2). 
2.1.2 Metabolism of Steroids 
 
Steroids are synthesised from cholesterol and then transformed into other 
steroids. The pathways of steroidogenesis differ among different species; the 
pathways of human steroidogenesis are shown in the Figure 2.2. The anabolic 
androgenic steroids are extensively and notably metabolized in the liver and their 
target tissues. The metabolism of anabolic androgenic steroids generally follows the 
metabolic pathways observed for testosterone metabolism that has been 
comprehensively reviewed (Schӓnzer, 1996 and Van Eenoo & Delbeke, 2006). 
Metabolism conversion is categorized into Phase I and II reactions. In phase I 
reactions enzymatically catalyzed alterations are observed, mainly oxidations and 
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reductions, which help convert the steroids into more polar compounds in order to 
inactivate the drug and facilitate its elimination from the body. Phase II reactions 
conjugate the steroids or their metabolites mainly with glucuronic acid or sulphate. 
They also help in the elimination of steroids from the body (Schӓnzer, 1996). 
Testosterone belongs to the androgen group, which is required for the development 
of male secondary sex characteristics. Androgens on the other hand embed the 
following derivatives: dehydroepiandrosterone (DHEA), androstenedione, 
androstenediol, testosterone (T), androsterone, and dihydrotestosterone. DHEA 
(Figure 2.3-1) is one of androgen derivatives from pregnenolone without the 
conversion of progesterone; it represents a different synthetic pathway from 
testosterone. It has the same molecular weight as testosterone, and shares a similar 
structure to testosterone among the androgens. Epitestosterone (E), an epimer of 
testosterone at C-17, is an inactive form of testosterone; it has no anabolic or 
androgenic effects. Its role in the body and the exact pathway of its formation is still 
unknown (Bellemare et al., 2005). A study has shown that half of epitestosterone is 
produced in the testis, and it accumulates in mammary cyst fluid and in the prostate. 
Antiandrogenic activity and neuro protective effects are also found. Though it varies 
among individuals, the ratio of epitestosterone to testosterone that is naturally 
excreted into human urine is approximately 1:1 (Bellemare et al., 2005). Glucuronide 
conjugates of testosterone and epitestosterone are formed by glucuronosyltransferase 
in liver microsomes and uridine diphosphoglucuronicacid, and excreted in urine 
through steroid hormone metabolism (Schӓnzer, 1996). 
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Figure2. 2 Steroidogenesis (Adapted from Krone et al., 2010) 
   10 
 
 
Figure 2. 3 Metabolic scheme of testosterone and its prohormones: 1, dehydroepiandrosterone; 2, androst-5-ene-3β,17β-diol; 3, androst-5-
ene-3,17-dione; 4,androst-4-ene-3,17-dione; 5, testosterone; 6, androst-4-ene-3β,17 β -diol; 7, 5α- and 5β -androstandione; 8, 5αand 5β -
dihydrotestosterone; 9, 5β -androstan-3β,17β -diol; 10, androsterone (5α)and etiocholanolone (5 β); 11, 5α - and 5β -androstan-3α,17β -diol; 
12, 5α -androstan-3βα,17β –diol (adapted from: Eenoo & Delbeke, 2006) 
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2.2 Detection of Anabolic Androgenic Steroids in Human Urine in Doping 
Control 
 
2.2.1 History of Testing 
 
The use of anabolic androgenic steroids by athletes for the purpose of 
enhancing their performance was first reported in 1950s (Kam & Yarrow, 2005). 
After the Munich Olympics in 1972, widespread abuse of steroids in sports was 
realized. Such a misuse has led to the addition of anabolic androgenic steroids to the 
list of banned substances by the International Olympic Committee. Its Initial tests 
relied on radioimmunoassay (RIA). RIAs were developed for detecting three steroid 
groups: 17-methylated steroids, 17-ethylated steroids and nandrolone. Large scale 
detection of anabolic androgenic steroids abuse was first executed in the Montreal 
Olympics in 1976 using RIA for screening and GC/MS with magnetic sector 
analyzer for confirmation purposes. Insufficient cross-reactivity towards different 
AAS and their metabolites and the high non-specificity have limited the usefulness 
of RIA, although it was used only as a screening test. In early 1980s, rapid 
improvements in mass spectrometers allowed doping control laboratories to develop 
specific, sensitive and comprehensive screening and confirmation methods for the 
detection of steroid abuse (Bowers et al., 2009). 
2.2.2 Strategy of Testing 
 
In sport drug testing, AAS are presently analyzed only from urine samples. In 
general, the measurements are qualitative in nature; however the detection of the 
natural steroids abuse those are structurally identical to those produced endogenously 
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like testosterone; requires quantification. All methods used are based on 
chromatography combined with mass spectrometry. Depending on the steroids, the 
required performance limit is either 2 or 10 ng/mL. Currently, laboratories routinely 
analyze samples only for the presence of free and glucuronide-conjugated steroids 
(WADA, TD2009MRPL). 
The analysis of AAS as well as of other banned substances is divided into 
two categories: the screening procedures and the methods of confirmatory analysis. 
The aim of screening is to put suspicious samples under further analysis. An ideal 
screening method should be simple, fast, selective, sensitive and not prone to 
wastage of sample unnecessarily. Because of the large number of banned substances, 
multi-analyte screening methods are favored in order to keep the number of separate 
procedures at the minimum (Kicman & Gower, 2003) 
All presumptive positive samples found by screening are confirmed by 
reanalyzing them along with a drug-free sample and with appropriate reference 
samples using highly specific and sensitive analytical methods. Drugs are verified by 
their chromatographic retention times and by mass spectral properties compared to 
certified reference compounds. Confirmation measurements are recommended to be 
performed in full scan mode; however, the confirmation of low concentrations is 
permissible using monitoring of selected ions. The criteria of identification are 
strictly specified in order to harmonize the practice and to ensure defensible results 
(Hatton & Catlin, 1987) 
2.2.3Analytical Techniques for Detecting Steroids 
The basic method to detect AAS was developed by Donike et al. Their 
analyses were performed on bench-top quadrupole MS coupled with capillary GC. 
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Samples were cleaned up using XAD-2 solid phase material, followed by hydrolysis 
of conjugated metabolites using β-glucuronidase enzyme and liquid-liquid extraction 
(LLE) with diethyl ether at alkaline pH (Shackleton, 2009). Prior to GC/MS in 
selected ion monitoring mode (SIM), steroids were derivatized with a mixture of N-
methyl-N-(trimethylsilyl) trifluoroacetamide (MSTFA), trimethyliodosilane and 
antioxidant to convert steroid hydroxyl and keto groups to their unique 
trimethylsilyl(TMS) ethers and enol ethers (Bowden et al., 2009). Modifications 
from the original method include for example solid phase extraction (SPE) with C18 
cartridges, LLE with tertbutyl methyl ether and a combination of pretreatment and 
finally an analysis of free and conjugated steroids. The latest variation includes direct 
hydrolysis of urine, followed by LLE and derivatzation using deuterated 
androsterone glucuronide and etiocholanolone for quality assurance. A typical 
GC/MS-SIM run takes 20-30 min and incorporates 10-15 time to program the 
acquisition groups of 15-20 ions. Depending on the steroid, the limit of detection 
(LOD) between 2-30 ng/mL can be achieved. Negative and positive ion chemical 
ionization has been applied to different derivatives of many AAS metabolites but 
without any significant enhancement in terms of sensitivity. Since sufficient LOD are 
not achieved for all steroids with the basic method, laboratories have been obliged to 
search for complementary analytical methods to screen and confirm steroids 
(Shackleton, 2009). 
The development of GC/MS showed steady progress over the next 40 years; a 
matter that results in the inexpensive and robust bench-tops that are used today. In  
doping control, full steroid profile was fundamentally introduced as it undoubtedly 
could form a part of ‘Athletes Biological Passport’ that is currently being proposed 
for all athletes (Shackleton, 2009). Athletes Biological Passport is a collection of 
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carefully selected individual information which will assist Anti-Doping 
Organizations in differentiating between deviations of specific markers that may be 
naturally occurring from those deviations that are likely caused by doping (Sottas et 
al., 2010). 
2.2.3.1 Measurement of Steroids by Chromatography and Mass Spectrometry 
 
 Due to significant advances in mass spectrometry (MS) technology, the 
routine analyses of steroid hormones are facilitated in clinical and research 
laboratories. Nowadays, clinical laboratories can achieve greater throughput of 
patient samples with high accuracy and precision. In addition to that, the MS 
methodology is now sufficiently rapid and robust for quantitating steroid hormones.  
In the past decades, high performance liquid chromatography (HPLC) 
coupled with tandem mass spectrometry (LC/MS/MS) has a significant development 
on steroid hormones analysis. Besides that, the development of an electrospray 
source by Nobel Laureate John B. Fenn, PhD., 1990, and the subsequent 
development of atmospheric chemical ionization have facilitated routine analysis of 
steroids in clinical laboratories (Fenn et al. 2005). Such a technological progress has 
facilitated the ionization of the analytes present in liquid droplets and sprayed the 
molecules directly into the mass spectrometer from the HPLC. This advancement has 
further allowed having a simple coupling of the liquid chromatography (LC) eluent, 
which reduces the complexity of the assay and shortens the assay run time 
dramatically (Stanczyk & Clarke, 2010).Most of the liquid chromatography mass 
spectrometry (LC/MS) based methods for the detection of anabolic steroids 
usedtandem mass instruments in selected reaction monitoring (SRM) mode due to its 
specificity and selectivity. Additionally, the selection of a specific SRM transition 
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can minimize the endogenous urinary interferences. Using this approach, free or 
conjugated steroids could be detected in different doping relevant matrices such as 
human and horse urine, dietary supplements, plasma or hair. The main limitation of 
this approach (common to all LC/MS approaches) is the poor ionization efficiency of 
steroids in electrospray ionization; this is especially so for steroids that do not have a 
conjugated keto moiety (Pozo et al., 2011). In addition, LC typically does not 
provide resolution as high as that of GC and can have difficulty in separating 
analytes with a very closely related structure (Stanczyk & Clarke, 2010). 
While the advent of LC-MS/MS in the past decades has resulted in dramatic 
improvements in the sensitivity, specificity and automation of serum steroid hormone 
measurements, there are still situations where a GC/MS or GC/MS/MS assay 
provides higher chromatographic resolution and even sensitivity. A particular 
strength of GC-MS and GC-MS/MS is their high applicability to measure large 
numbers of structurally similar analytes. Accordingly, they have remained the most 
powerful discovery tool for defining steroid disorder metabolites. 
2.2.3.1.1 Mass Spectrometry 
 
The mass spectrometer consists of an ion-source, a mass analyser, a detector 
and a data system (Figure 2.4). Sample molecules are admitted to the ion-source 
where they are vaporised and ionised. The ions are then separated according to their 
mass-to-charge ratio (m/z) in the mass analyser and are finally detected. The resulting 
signals are transmitted to the data system and a plot of ion-abundance against m/z 
corresponds to a mass spectrum. In many cases, a separating inlet device precedes 
the ion-source, so that complex mixtures can be separated prior to admission to the 
mass spectrometer. Today, the separating inlet device is usually either a capillary 
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gaschromatographic (GC) column or a high performance liquid chromatographic 
(HPLC) column, although the capillary electrophoresis or thin layer chromatography 
can also be interfaced with mass spectrometry (Watson & Sparkman, 2007) 
 
Figure 2. 4 Schematic diagram for Mass Spectrometer 
 
Mass spectrometry technique was used for the steroid metabolism by the late 
1930. Currently, the most common type of MS analyzer in doping analysis is the 
single quadrupole MS system, which can be used either in the full scan mode or in 
selected ion or selected ion monitoring (SIM) mode in screening protocols. GC was 
the first analytical techniques used to detect prohibited substances in athletes like 
anabolic agent and GC/MS has become the workhouse of doping control laboratories 
worldwide. Screening of these substances is performed by either using the full scan 
mode or SIM mode with single quadrupole mass analyzer. SIM can also be used for 
confirmation of a suspect positive by determining the relative ratios of the multiple 
ions being monitored for each target compound and comparing these to the ratios 
obtained for authentic standards (Latiff & Churley, 2009). 
A GC/MS system in full scan mode will monitor a range of masses known as 
mass to charge ratio. A typical mass scan range will cover from 35-500 m/z four 
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times per second and will detect compound fragments within that range over a set 
period of time. Laboratories have extensive computer libraries that contain mass-
spectra of many different compounds that can be compared to the unknown analyte 
spectrum. The full scan mode is very useful when identifying unknown compounds 
in a sample and providing confirmation of results from GC using other types of 
detectors. 
Operating GC/MS in SIM mode allows for the detection of specific analytes 
with increased sensitivity relative to full scan mode. In SIM mode, the MS gathers 
data for masses of interest rather than looks for all masses over a wide range. 
Because the instrument is designed to look for only masses of interest, it can be 
specific for a particular analyte of interest. Typically, two to four ions are monitored 
per compound and the ratios of those ions will be unique to the analyte of interest. In 
order to increase sensitivity, the mass scan rate and dwell time, which is the time 
spent in looking at each mass should be adjusted. 
2.2.3.1.2 Gas Chromatography/Tandem Mass Spectrometry 
 
Enhancement in sensitivity and selectivity can also be obtained using MS/MS 
by monitoring selected product ions that formed in collision-induced dissociation of 
a precursor ion (Watson & Sparkman, 2007). Most steroids could be analyzed at 
concentrations lower than the required performance limits of 2 and 10 ng/mL 
(WADA, TD2010 MRPL). Improvements in the LOD along with a better selectivity, 
helped shorten the overall analysis time significantly. Van Eenoo et al. (2011) have 
described a GC/MS/MS method for detecting a wide range of different doping 
agents. AAS or their metabolites could be analyzed within 8 minutes. MS/MS 
measurements of AAS have been mostly carried out with quadrupole ion trap 
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instruments. In addition to screening purposes, MS/MS has been used in 
confirmatory analysis. 
2.2.3.1.2.1 Principle of Gas Chromatography/Tandem Mass Spectrometry 
(GC/MS/MS) 
When a second phase of mass fragmentation is added; for example using a 
second quadrupole in a quadrupole instrument, it is called tandem MS (MS/MS). 
MS/MS can sometimes be used to quantitate low levels of target compounds in the 
presence of a high sample matrix background. 
The first quadrupole (MS1) is connected to a collision cell (MS2) and another 
quadrupole (MS3) (Figure 2.5). Both quadrupoles can be used in scanning or static 
mode, depending on the type of MS/MS analysis being performed. The types of 
analysis include product ion scan, precursor ion scan, Selected Reaction Monitoring 
(SRM) (sometimes referred to as Multiple Reaction Monitoring (MRM)) and Neutral 
Loss Scan. For example, when MS1 is in static mode (looking at one mass only as in 
SIM), and MS3 is in the scanning mode, the product ion spectrum which is also 
called daughter spectrum can be obtained. From this spectrum, a prominent product 
ion is selected which can be the product ion for the chosen precursor ion. The pair is 
called a transition that forms the basis for SRM. The latter is characterized by being 
highly specific and by its ability to eliminate the matrix background virtually. 
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Figure 2. 5 Schematic diagram of  MS/MS adapted from: 
http://www.medandlife.ro/medandlife418.html. Retrieved 28/9/2011  
 
There are four main possible scan experiments that can be conducted by 
using MS/MS. Product ion scan in which the first MS is set to select an ion of a 
known mass, will be fragmented in the second MS. The third MS is then set to scan 
the entire m/z range, giving information on the fragments produced. From the ion 
fragmentation information, the structure of the original ion can be deduced. This 
experiment is commonly performed to identify the transitions used for the 
quantification by tandem MS. When using the precursor ion scan, a certain product 
ion is selected in third MS, and the precursor masses are scanned in the first MS. In 
Neutral loss scan mode, both the first MS and the third MS are scanned together, but 
with a constant mass offset. This allows the selective recognition of all ions which 
have been fragmentated in the second MS; a matter that leads to the loss of a given 
neutral fragment (e.g., H2O, NH3). Similar to the precursor ion scan, this technique is 
also useful in the selective identification of closely related class of compounds in a 
mixture. The fourth type is the selected reaction monitoring (SRM)/ Multiple 
reaction monitoring (MRM). Both the first and third MS are set to a selected mass, 
allowing only a distinct fragment ion from a certain precursor ion to be detected. 
This technique is a very selective analysis mode, which can result in increased 
sensitivity (Watson & Sparkman, 2007). 
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2.2.3.1.2.2 Advantages and Application of GC/MS/MS: 
 
The triple quadrupole MS provides superior sensitivity and selectivity for the 
compound analysis in a complex matrix in comparison to the single quadrupole MS. 
This is because of the specificity of tandem MS. Moreover, one of the important 
advantages is the elimination of background interferences that allows a very low 
detection limits for quantification like femtograms. Improvements in MS sensitivity 
are achieved through increasing the signal strength and reducing the chemical noise. 
 The GC/MS/MS instrument is very robust in high throughput application 
areas which include pesticides and herbicides that can be encountered in foods 
especially food those that have very complex volatile backgrounds. The GC/MS/MS 
has been shown to analyse tetrahydrocannabinol (THC) derivatives at low detection 
limits. Besides, it also shows great promise in the analysis of human fluids in case of 
intaking drugs and drugs of abuse. 
The strength of tandem MS is the one that does not need to know the 
structure of an analyte to detect it. Rather, some very specialized operational modes 
can be used to identify compounds that have chemical resemblances to other well 
understood compounds in a homologous series of compounds. An example of this 
can be found during the process of identifying metabolites of new therapeutic entities 
after being administrated to laboratory animals or human )Clarke et al., 2001). 
A Chinese study investigated the physiological concentration of anabolic 
steroids in human hair of Chinese subjects by using GC/MS/MS. The measurement 
of anabolic steroids in hair is necessary in order to distinguish between the 
pharmaceutical steroids and natural steroids (Shen et al., 2009). 
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Another GC/MS/MS method was developed and applied to the analysis of 
Chinese cooked foods. The results demonstrated the potentiality of the GC/MS/MS 
method in analyzing trace food-derived hazardous compounds in a complex food 
matrix such as meat samples (Zhang et al., 2008). 
In addition, another scientist showed that GC/MS/MS can be used for 
determining of pesticide residues in crops and dry animal feed. This is because it  
gives a much higher degree of certainty in analyte identification than in any single 
stage mass spectrometry technique. Such ability can be attributed to the fact that 
because isobaric interference are avoided and multiple-component spectra can be 
resolved. Thus, the confirmation of target analytes can be achieved with higher levels 
of confidence (Stanis, 2007). 
2.3 Eurycoma Longifolia Jack (Tongkat Ali) 
 
Eurycoma longifolia Jack is an herbal plant native to South East Asian 
countries, mainly Malaysia and Indonesia. It is popularly recognized as ‘Tongkat 
Ali’, which means the ‘walking stick’; that is derived from the presence of long 
twisted roots (consider Figure 2.6) (Bhat & Karim, 2010). 
Almost all parts of the Eurycoma longifolia plant have traditionally been used 
for therapeutic purposes. The plant extract have also been traditionally used due to its 
antimalarial, aphrodisiac and antipyretic activities (Kuo et al., 2003). The roots are 
the most valuable component and are used for the treatment of aches, persistent 
fever, malaria, sexual insufficiency, dysentery, glandular swelling, and as health 
supplements (Bhat & Karim, 2010). 
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Figure 2. 6 Eurycoma longifolia root (adapted from http://tong-kat-ali.com/buying-tongkat-
ali-extract.html) Retrieved 5/9/2011 
 
 
As mentioned before, the root extract of Eurycoma longifolia has gained wide 
recognition due to its unique feature of enhancing the virility and sexual competency, 
when the prepared extract is consumed. Besides, this plant has traditionally gained 
wide popularity for its aphrodisiac activities, it is necessary to validate the product 
for consumer safety and to declare that it safe for human consumption. Though 
several extensive researches are currently being undertaken worldwide, there is still a 
wide gap in the scientific information generated with reference to the human model 
system (Bhat& Karim, 2010). 
There has been a remarkable increase in the demand for the products of this 
plant. Moreover, nearly 200 of Eurycoma longifolia products highlighted the 
aphrodisiac properties, available in the health food market (Zanoli et al., 2009). 
Eurycoma longifolia products are available either in the form of raw crude powder of 
roots, as in the case of capsules mixed with other aphrodisiac herbs or as an additive 
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mixed with coffee and ginseng or in certain health products as a replacement for 
ginseng (Low & Tan, 2007). The regular intake of the root extracts is believed to 
enhance the testosterone levels. An increased interest has also been created among 
the athletes and individuals involved in body building with respect to using such an 
extract to enhance the muscle mass, strength and the overall performance (Bhat& 
Karim, 2010). 
2.3.1 Reviews on the biological effects of Eurycoma longifolia 
 
A review study on the ethanobotany and pharmacological importance of 
Eurycoma longifolia was carried out in 2010. Such study has stated that: “The plant 
parts have been traditionally used for its antimalarial, anti-diabetic, antimicrobial and 
anti-pyretic activities” (Bhat & Karim, 2010). Furthermore, there are many other 
important medical areas of interest in Eurycoma longifoliaas stated in the previous 
study. Most of the Southeast Asians consume it due to its positive impact on health. 
In 2001, Malaysian scientific researchers opened their peer-reviewed, Medline-
archived report on the effect of  Eurycoma longifolia on laboratory rats. The study 
maintained “that Eurycoma longifoliacommonly known as Tongkat Ali has gained 
notoriety as a symbol of man’s ego and strength by the Malaysian men” (David, 
2005). 
Another group of scientists confirmed that Eurycoma longifoliahas the 
capacity to reverse the inhibitory effects of oestrogen on testosterone (Nazrun et al., 
2010). Another study was conducted and found that the root of Eurycoma longifolia 
improved the sexual performance of male rats after acute administration. The authors 
suggest that the effect could be mainly ascribed to increasing the levels of 
testosterone in serum (Zanoli et al., 2009). In another experiment conducted on male 
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rats, it was reported that the extract of Eurycoma longifolia increased significantly 
the levels of plasma testosterone of treated rats in comparison to that of the control 
and infertile animals (Wahab et al., 2010). 
 After many scientific publications on the effects of Eurycoma longifolia, 
researchers in the field of sports medicine began to look into the anabolic potential of 
this plant. In a placebo-controlled human study with healthy young men in a weight 
training program, it was found that “the body mass of the treatment group showed a 
significant increment, from 52.26 kg to 54.39 kg (p=0.012)”. Furthermore, “the 
increased in strength in the treatment group was larger than in the placebo group 
(6.78% and 2.77% respectively)’’. The mean arm circumference of the treatment 
group increased significantly by 1.8 cm after the supplementation. However, there 
was no significant increase in the placebo group. The results suggested that the water 
soluble extract of Eurycoma longifolia increased fat free mass, reduced body fat, and 
increased muscle strength and size (Hamzah & Yusof, 2003). 
 The anabolic impact of Eurycoma longifolia has been also confirmed in the 
animal model, when the size and weight of just one muscle were measured in treated 
and untreated rats of equal size. The results showed that 800 mg/kg of butanol, 
methanol, water and chloroform fractions of Eurycoma longifolia have significantly 
increased (p<0.05) the levator ani muscle of the rats (Ang & Ngai, 2001).  
Due to these significant discoveries, a growing number of athletes and body- 
builders are now using the extract of Eurycoma longifoliaas an androgen to improve 
muscle size, strength, and enhance sport performance instead of using dangerous and 
potentially lethal steroids.  
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Apart from the anabolic and testosterone-related effects of Eurycoma 
longifolia, the antimalarial (Kuo et al., 2004), antibacterial (Kuo et al., 2003), 
antipyretic, antiulcer, antitumor (Miyake et al., 2010), and cytotoxic properties have 
been well documented. Taiwanese scientists isolated 65 biochemical compounds 
from the roots of Eurycoma longifolia. Out of this number of compounds, only ten 
exhibited strong cytotoxicity towards human lung and breast cancer cell lines 
(Miyake et al., 2010). Another group of researchers discovered several new 
biochemical compounds in Eurycoma longifolia and screened them for cytotoxic 
properties. They concluded that different fractions were effective against different 
types of cancers (Tee et al., 2005). In another study, the authors shared that fractions 
of Eurycoma longifolia extract induced apoptosis in cancer cells (Jackson et al., 
2010). 
  
 
 
  
